Medicrea acquired three new patents related to interbody devices.
Here are four key notes:
1. Medicrea acquired the patents from Paul McAfee, MD, of the University of Maryland St. Joseph's Medical Center in Towson. The patents addressed methodology to measure and plan interbody devices used in spine surgery.
2. The patents protect intellectual property around the technique for physiologically selecting interbody device height based on patient anatomy. The company expects these patents to compliment its UNiD ASI platform.
3. Medicrea takes a systems approach to spine with engineering services and in-house 3-D printing capabilities to create interbody device solutions optimized for the individual patient. The company's FDA-cleared IB3D and AdapTEK systems give surgeons control over implant design and dimensions.
4. The company will fully integrate its new patents into the proprietary UNiD HUB surgical planning software. "Combining data-driven planning techniques with the ability to deliver personalized implants will significantly reduce the inventory required for each case while ensuring the optimal implant is provided for the patient at each level operated," said Denys Sourmac, president and CEO of Medicrea.